{
    "organizations": [],
    "uuid": "2508cfd1b706be79c4955e3c52645a227e32a4d3",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-medreleaf-reports-q3-loss-per-shar/brief-medreleaf-reports-q3-loss-per-share-of-c0-05-idUSL8N1Q341F",
    "ord_in_thread": 0,
    "title": "MedReleaf reports Q3 loss per share of C$0.05",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "Feb 13 (Reuters) - Medreleaf Corp:\n* MEDRELEAF REPORTS THIRD QUARTER FISCAL 2018 RESULTS * QTRLY SALES OF $11.4 MILLION, AN INCREASE OF 9% FROM PRIOR YEAR PERIOD\n* QTRLY LOSS PER SHARE C$0.05 ‍​ * AT END OF DEC 31, 2017, CO HAD CASH AND CASH EQUIVALENTS OF $114.6 MILLION, WORKING CAPITAL OF $137.9 MILLION\n* Q3 EARNINGS PER SHARE VIEW C$-0.01 -- THOMSON REUTERS I/B/E/S\n* Q3 REVENUE VIEW C$11.2 MILLION -- THOMSON REUTERS I/B/E/S Source text for Eikon: Further company coverage:\n ",
    "published": "2018-02-13T20:18:00.000+02:00",
    "crawled": "2018-02-14T12:30:19.011+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "feb",
        "reuters",
        "medreleaf",
        "corp",
        "medreleaf",
        "report",
        "third",
        "quarter",
        "fiscal",
        "result",
        "qtrly",
        "sale",
        "million",
        "increase",
        "prior",
        "year",
        "period",
        "qtrly",
        "loss",
        "per",
        "share",
        "c",
        "end",
        "dec",
        "co",
        "cash",
        "cash",
        "equivalent",
        "million",
        "working",
        "capital",
        "million",
        "q3",
        "earnings",
        "per",
        "share",
        "view",
        "c",
        "thomson",
        "reuters",
        "q3",
        "revenue",
        "view",
        "c",
        "million",
        "thomson",
        "reuters",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}